Losartan improves regional left ventricular systolic and diastolic function in patients with hypertension: Accurate evaluation using a newly developed color-coded tissue Doppler imaging technique

Journal of Cardiac Failure

Volumn 10, Issue 5, 2004, Pages 412-420

  Tanaka, Hideji ^a,b   Oki, Takashi ^a,c,d   Tabata, Tomotsugu ^a,b   Yamada, Hirotsugu ^a,b   Harada, Kenji ^a,b   Kimura, Eriko ^a,b   Oishi, Yoshifumi ^a,c   Ishimoto, Takeo ^a,c   Ito, Susumu ^a,b  

^a University of Tokushima ^*

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c National Hospital Organization   (Japan)

^d National Hospital Organization   (Japan)

Author keywords

Hypertension; Losartan; LV systolic and diastolic function; Tissue Doppler imaging

Indexed keywords

LOSARTAN; TRANSFORMING GROWTH FACTOR BETA1; ANGIOTENSIN 2 RECEPTOR; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; IMAGING; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTOLE; TECHNIQUE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; DRUG ANTAGONISM; DRUG EFFECT; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; MIDDLE AGED; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 2; REGRESSION ANALYSIS; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 21644488310     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.01.007     Document Type: Article

References (29)

1. Weber KT, Brilla CG. Pathological hypertrophy and the cardiac interstitium: fibrosis and the renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.
2. Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Ubago JLM, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001;104:286-91.
3. Sasaki M, Oki T, Iuchi A, Tabata T, Yamada H, Manabe K, et al. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens 1996;14: 1403-8.
4. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102:1388-93.
5. 1 receptor subtype. Circ Res 1993; 73:413-23.
6. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Ubago JLM. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105:2512-7.
7. Wachtell K, Dahlof B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, et al. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the losartan intervention for end-point reduction in hypertension (LIFE) study. Am Heart J 2002;144: 1057-64.
8. Oki T, Tabata T, Yamada H, Wakatsuki T, Shinohara H, Nishikado A, et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997;79:921-8.
9. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
10. Uematsu M, Miyatake K, Tanaka N, Matsuda H, Sano A, Yamazaki N, et al. Myocardial velocity gradient as a new indicator of regional left ventricular contraction: detection by a two-dimensional tissue Doppler imaging technique. J Am Coll Cardiol 1995;26:217-23.
11. Yamada H, Oki T, Tabata T, Mishiro Y, Abe M, Onose Y, et al. Assessment of the systolic left ventricular myocardial velocity profile and gradient using tissue Doppler imaging in patients with hypertrophic cardiomyopathy. Echocardiography 1999;16:775-83.
12. Fujimoto S, Oki T, Tabata T, Tanaka H, Yamada H, Oishi Y, et al. Novel approach to the quantitation of regional left ventricular systolic and diastolic function using tissue Doppler imaging to create a myocardial velocity profile and gradient. Circ J 2003;67:416-22.
13. Derhaschnig U, Shehata M, Herkner H, Bur A, Woisetschlager C, Laggner AN, et al. Increased levels of transforming growth factor-1 in essential hypertension. Am J Hypertens 2002;15:207-11.
14. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19: 1550-8.
15. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-8.
16. Hartford M, Wikstrand JCM, Wallentin I, Ljungman SMG, Berglund GL. Left ventricular wall stress and systolic function in untreated primary hypertension. Hypertension 1985;7:97-104.
17. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991;69:107-15.
18. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis. Hypertension 2001;37:1047-52.
19. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996;275:1507-13.
20. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, et al. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 1984;53:120-6.
21. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002;359:995-1003.
22. Varo N, Etayo JC, Zalba G, Beaumont J, Iraburu MJ, Montiel C, et al. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 1999;17:107-14.
23. 1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 2000;35:1197-202.
24. Oki T, Tabata T, Yamada H, Wakatsuki T, Mishiro Y, Abe M, et al. Left ventricular diastolic properties of hypertensive patients measured by pulsed tissue Doppler imaging. J Am Soc Echocardiogr 1998;11: 1106-1112.
25. Derumeaux G, Mulder P, Richard V, Chagraoui A, Nafeh C, Bauer F, et al. Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats. Circulation 2002;105:1602-8.
26. Palka P, Lange A, Fleming AD, Donnelly JE, Dutka DP, Starkey IR, et al. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. J Am Coll Cardiol 1997;30:760-8.
27. Mishiro Y, Oki T, Yamada H, Onose Y, Matsuoka M, Tabata T, et al. Use of angiotensin II stress pulsed tissue Doppler imaging to evaluate regional left ventricular contractility in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2000;13:1065-73.
28. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SWL. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002;105:1195-201.
29. Vogel M, Cheung MMH, Li J, Kristiansen SB, Schmidt MR, White PA, et al. Noninvasive assessment of left ventricular force-frequency relationships using tissue Doppler-derived isovolumic acceleration. Validation in an animal model. Circulation 2003;107:1647-52.